Clinical research conducted with participation from Florida Cancer Specialists & Research Institute, LLC (FCS) continues to ...

Study reveals potential of AI-powered tumor microenvironment assessment in predicting treatment outcomes in rare cancer patients receiving ...

Advertisement Specific types of immune cells unleashed by cancer immunotherapy appear to cause myocarditis ... Nov. 7 (UPI) - ...

Head and neck diseases contain tumors, infections, inflammation, and other lesions. These diseases often involve tissues in the mouth, throat, larynx, nasal cavity, paranasal sinuses, ears, and neck.

A2 Bio shares clinical study progress and the increased diversity of participants in the BASECAMP-1 prescreening study during ...

The 22nd Annual Winter Lung Cancer Conference, January 31-February 2, 2025, will cover advances in NSCLC and SCLC treatment.

AMPLIFY-7P Phase 2 randomized study anticipated to complete enrollment in Q4 2024; formal interim analysis of disease-free survival (“DFS”) expected in H1 2025 Poster presentation at the Society for ...

Infinitopes, an integrated cancer biotech combining world leading platforms in precision antigen discovery with vaccine vectors capable of durably stimulating protective immune responses, today ...